Certified by Founder Lodge
Koneksa
United States - New York
START UP
1 Disclosed Funding Rounds $45,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Kon
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 08 ,2022 | Series C | $45,000,000 |
Takeda Ventures, Inc.
Waterline Ventures
McKesson Ventures
Spring Mountain Capital
Truemeds India
Receptor Life Sciences, Inc.
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
